PMID: 15252269Jul 15, 2004Paper

Clozapine treatment in oromandibular dystonia

Clinical Neuropharmacology
Hasmet A HanagasiMurat Emre

Abstract

Oromandibular dystonia (OMD) is a form of focal dystonias, which can be associated with substantial disability and is frequently refractory to all antidystonic therapies. Clozapine is a dibenzodiazepin derivative atypical neuroleptic that has been reported to be effective in the treatment of primary or symptomatic dystonia. We report here two patients with severe OMD refractory to other antidystonic therapies, who had substantial improvement with clozapine. We suggest that clozapine should be considered in patients with OMD who fail to response to other treatments.

References

Aug 1, 1990·Journal of Neurology, Neurosurgery, and Psychiatry·J JankovicD T Donovan
Jan 1, 1990·Movement Disorders : Official Journal of the Movement Disorder Society·J H Friedman, M C Lannon
Feb 1, 1989·The Annals of Otology, Rhinology, and Laryngology·A BlitzerS Fahn
Jan 1, 1988·Movement Disorders : Official Journal of the Movement Disorder Society·P GreeneS Fahn
Jan 1, 1988·Movement Disorders : Official Journal of the Movement Disorder Society·J G NuttL J Melton
May 31, 1971·JAMA : the Journal of the American Medical Association·H D SutcherO Sugar
May 1, 1994·Movement Disorders : Official Journal of the Movement Disorder Society·J H Friedman
Jul 1, 1994·Movement Disorders : Official Journal of the Movement Disorder Society·J M TrugmanG F Wooten
May 1, 1994·Neurology·U BonuccelliA Muratorio
May 1, 1994·Neurology·A ThielE Rüther
Jul 15, 1993·The New England Journal of Medicine·J M AlvirJ A Schaaf
Jun 15, 1996·Biological Psychiatry· Adityanjee, A B Estrera
Feb 1, 1996·Progress in Neuro-psychopharmacology & Biological Psychiatry·P N Van HartenG E Matroos
Sep 1, 1996·Movement Disorders : Official Journal of the Movement Disorder Society·M RajaA Albanese
Jul 1, 1997·Movement Disorders : Official Journal of the Movement Disorder Society·S A Factor, J H Friedman
Nov 14, 1997·Neuroscience and Biobehavioral Reviews·S A JosselynR J Beninger
Jun 5, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·R M TroschW C Koller
Jul 21, 1998·Journal of Neurology·P BurbaudB Bioulac
Aug 6, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·B I KarpM Hallett
Jan 25, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·E K Tan, J Jankovic
Jul 24, 2001·European Psychiatry : the Journal of the Association of European Psychiatrists·M LanzaroA D'Ambrosio
Feb 9, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Charles H AdlerKapil D Sethi

❮ Previous
Next ❯

Citations

Jul 12, 2012·Therapeutic Advances in Neurological Disorders·Cathérine C S Delnooz, Bart P C van de Warrenburg
May 22, 2009·Parkinsonism & Related Disorders·Mark S LeDoux
Aug 11, 2007·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Kai H Lee
Nov 8, 2005·Parkinsonism & Related Disorders·Carlos Singer, Spiridon Papapetropoulos
Dec 7, 2013·Asian Journal of Psychiatry·Nandita HazariSandeep Grover
Jun 20, 2015·Neurorehabilitation and Neural Repair·Sharyl SamargiaTeresa Jacobson Kimberley
Sep 15, 2015·Clinical Neuropharmacology·Narsimha Reddy PinnintiAdit Adityanjee
Dec 4, 2019·Clinical Parkinsonism & Related Disorders·Steven Bellows, Joseph Jankovic

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Movement Disorders : Official Journal of the Movement Disorder Society
B I KarpM Hallett
Movement Disorders : Official Journal of the Movement Disorder Society
I MaurerC E Elger
Journal of Neurology, Neurosurgery, and Psychiatry
K P BhatiaC D Marsden
© 2022 Meta ULC. All rights reserved